MERRITT BORDERS: Open Payments
NPI 1942817762 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 53 payments from 19 companies in 2025. Trend: 2023 $841 · 2024 $817 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $237 |
| Indivior Inc. | 7 | $138 |
| Gilead Sciences, Inc. | 4 | $102 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| ABBVIE INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| PFIZER INC. | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
| Braeburn Inc. | 2 | $41 |
Products named: AUSTEDO XR, SUBLOCADE, INGREZZA, UZEDY, VRAYLAR, REXULTI, Kerendia, CAPLYTA.
Industry payments across KY — which companies pay providers there.
